Primary Systemic Amyloidosis — Trials

Primary Systemic Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01728259	First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD	terminated	Phase 1	18	Barbara Ann Karmanos Cancer InstituteOTHER	2	May 9, 2023	clinicaltrials
NCT00030381	Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis	terminated	Phase 1	22	National Cancer Institute (NCI)NIH	1	Jan 16, 2013	clinicaltrials

Data updated 22 days agoSource updated May 9, 2023source: clinicaltrials